Paroxysmal Atrial Fibrillation Clinical Trials
4 recruiting trials for Paroxysmal Atrial Fibrillation. Eligibility criteria explained in plain English.
TrialFinderData lists 4 Paroxysmal Atrial Fibrillation clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Medtronic Cardiac Ablation Solutions (1), Virginia Commonwealth University (1), Northwell Health (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Arctic Front™ Cardiac Cryoablation Catheter (device, 1 trial), followed by Self- Report Evaluation-Duke Activity Status Index, Self- Report Evaluation Atrial Fibrillation Effect on Quality of Life Questionnaire.
Track Paroxysmal Atrial Fibrillation trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
STOP AF First Post-Approval Study
The STOP AF First PAS is a prospective, global, multi-center, observational trial.
EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation
Longitudinal, observational cohort study to evaluate changes in left atrial (LA) reservoir function during exercise and overall exertional capacity in patients following catheter...
Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)
This is a prospective, descriptive study. Safety endpoints will not be assessed. All eligible patients that have a history of paroxysmal atrial fibrillation and an indication to...
Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke
Stroke recurrence largely depends on the detection of the cause and the control of vascular risk factors, with occult atrial fibrillation (AF) being one of the most important....
Explore Other Conditions
Frequently Asked Questions
There are currently 4 clinical trials for Paroxysmal Atrial Fibrillation, with 4 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Paroxysmal Atrial Fibrillation, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Paroxysmal Atrial Fibrillation, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.